欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/0356/006
药品名称
Certican
活性成分
Everolimus 0.25 mg
剂型
Dispersible tablet
上市许可持有人
Novartis Sverige AB Sweden
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Germany (DE)
Denmark (DK)
Belgium (BE)
Netherlands (NL)
Luxembourg (LU)
Austria (AT)
Certican 0,25 mg - Tabletten zur Herstellung einer Suspension zum Einnehmen
France (FR)
Spain (ES)
Italy (IT)
Norway (NO)
Finland (FI)
Hungary (HU)
许可日期
2003/12/02
最近更新日期
2025/01/08
药物ATC编码
L04AA18 everolimus
申请类型
TypeLevel1:
New Active Substance
TypeLevel2:
Additional Strength/Form
TypeLevel3:
Full Dossier Article 4.8 Di 65/65
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
SE_H_0356_006_Final PL
Date of last change:2024/09/06
Final SPC
|
SE_H_0356_006_Final SPC
Date of last change:2024/09/06
PubAR
|
SE_H_0356_006_PAR
Date of last change:2024/09/06
PubAR Summary
|
SE_H_0356_006_PAR Summary
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase